AlphaRet Investor Presentation
Filed with ASX · · 11 pages · English
This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is made as to the accuracy, adequacy or reliability of any statement, estimates, opinions or other information contained in the presentation. This presentation may contain
In the deck
Story so far
Earlier from Nova Eye Medical
- 2RT Pivotal Study and Regulatory Pathway
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
- Investor presentation Half Year Results 31 December 2021
- Half year results discussion
- Glaucoma Sales Update
Later from Nova Eye Medical
- iTrack Advance Commercial Roll-Out Commenced
- Appendix 4E and Annual Report FY22
- Investor Presentation FY22
- Results Announcement FY22
- Clarification Glaucoma Surgical Devices Sales Update
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical